Zimmer in frame for number-two ortho spot with $13bn Biomet buy
This article was originally published in Clinica
Executive Summary
Just over a month after saying it was going public again, Biomet is now to be acquired by number-three orthopedic player Zimmer for $13.35bn in a combination of cash and stock. Warsaw, Indiana-based Biomet was ranked number 6 in Clinica’s Top 20 Orthopedics league table last year, and the purchase looks set to catapult Zimmer to the number-two position in the market. It is also easily the biggest buy of 2014 so far.